SNGX Stock Catalyst: Soligenix Transfers Manufacturing Process for Synthetic Hypericin Active Ingredient

Jun 30, 2025 · 7:24pm ET

Partnership agreement with Sterling Pharma Solutions

Max move

+101.5%

High of day $2.70

Sparker timei

7:24pm ET

SNGX · Jun 30, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Soligenix, Inc. has transferred the manufacturing process for the synthetic hypericin active ingredient to Sterling Pharma Solutions under a partnership agreement. This strategic move aims to enhance production capabilities and efficiency.

No financial amounts or filings were disclosed in the announcement. The partnership focuses on leveraging Sterling Pharma Solutions' expertise in manufacturing to support Soligenix's product development.

Soligenix has a free float of 9,362,300 shares and 10,086,100 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time SNGX sparks.

Download Sniper App →

Catch the next SNGX-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →